🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Abdul Karzai

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0002-4540-8339

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN”.

PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0026

N/A

0DataRank · unranked

81 citations

Neha Bhagwat, Alessandro Pastore, Aliaksandra Radzisheuskaya, Abdul Karzai, Aishwarya Krishnan +21 more

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.08.471791

N/A

0DataRank · unranked

6 citations

Dongjoo Kim, Min Lü, Mirko Farina, Julie L. Yang, Young Joo Park +29 more

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

Blood(2023)10.1182/blood.2022015418

N/A

0DataRank · unranked

37 citations

Dongjoo Kim, Min Lü, Mirko Farina, Robert L. Bowman, Julie L. Yang +34 more

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Cancer Discovery(2024)10.1158/2159-8290.cd-22-0952

N/A

0DataRank · unranked

30 citations

Robert L. Bowman, Young C. Park, Kavi O’Connor, Franco Izzo, Robert M. Myers +29 more